Medtech in a Minute: Dexcom, Medtronic, and Baxter

The news you need. In one minute or less.

Amanda Pedersen

March 11, 2024

1 Min View
Graphic for the weekly Medtech in a Minute feature on MD+DI, a roundup of top medical device news in brief from the week.
Image by MD+DI

Video transcript:

Voice Over: Dexcom Brings CGM to the Masses. FDA cleared the first glucose biosensor available without a prescription.

Medtronic Goes After Axonics Again. Medtronic says Axonics is illegally using its MRI compatibility tech. Axonics says Medtronic is trying to stifle competition. Meanwhile, Boston Scientific is in the process of buying Axonics.

Baxter Backpedals on Kidney Spinoff. Baxter may sell its kidney care business to private equity investors instead of its previous spin-off plans announced last year.

About the Author(s)

Amanda Pedersen

Amanda Pedersen is a veteran journalist and award-winning columnist with a passion for helping medical device professionals connect the dots between the medtech news of the day and the bigger picture. She has been covering the medtech industry since 2006.

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like